Anuradha Pandey

Pilani, RJ, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Learning From Biological and Computational Machines: Importance of SARS-CoV-2 Genomic Surveillance, Mutations and Risk Stratification.

Learning From Biological and Computational Machines: Importance of SARS-CoV-2 Genomic Surveillance, Mutations and Risk Stratification.

Journal: Frontiers in cellular and infection microbiology

Published: September 27, 2021

Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.

Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.

Journal: Indian journal of pharmacology

Published: March 09, 2018

AT2 receptor agonist Compound 21: A silver lining for diabetic nephropathy.

AT2 receptor agonist Compound 21: A silver lining for diabetic nephropathy.

Journal: European journal of pharmacology

Published: June 05, 2017

Compound 21 and Telmisartan combination mitigates type 2 diabetic nephropathy through amelioration of caspase mediated apoptosis.

Compound 21 and Telmisartan combination mitigates type 2 diabetic nephropathy through amelioration of caspase mediated apoptosis.

Journal: Biochemical and biophysical research communications

Published: April 16, 2017

Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes.

Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes.

Journal: British journal of pharmacology

Published: December 09, 2016

Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway.

Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway.

Journal: Pharmacological reports : PR

Published: September 22, 2016

Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis.

Histone H2AK119 and H2BK120 mono-ubiquitination modulate SET7/9 and SUV39H1 in type 1 diabetes-induced renal fibrosis.

Journal: The Biochemical journal

Published: June 20, 2016

H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats.

H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats.

Journal: Biochimie

Published: May 23, 2016

E3 ubiquitin ligases as novel targets for inflammatory diseases.

E3 ubiquitin ligases as novel targets for inflammatory diseases.

Journal: Pharmacological research

Published: January 09, 2016

Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.

Insulin sensitizing and cardioprotective effects of Esculetin and Telmisartan combination by attenuating Ang II mediated vascular reactivity and cardiac fibrosis.

Journal: European journal of pharmacology

Published: June 18, 2015

Nanoparticles: A Neurotoxicological Perspective.

Nanoparticles: A Neurotoxicological Perspective.

Journal: CNS & neurological disorders drug targets

Published: May 28, 2015

FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?

FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?

Journal: Current diabetes reviews

Published: April 20, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026